Logo image of AXA.DE

AXA SA (AXA.DE) Stock Fundamental Analysis

FRA:AXA - Deutsche Boerse Ag - FR0000120628 - Common Stock - Currency: EUR

41.46  -0.32 (-0.77%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AXA. AXA was compared to 39 industry peers in the Insurance industry. Both the profitability and the financial health of AXA get a neutral evaluation. Nothing too spectacular is happening here. AXA is not valued too expensively and it also shows a decent growth rate. AXA also has an excellent dividend rating. With these ratings, AXA could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AXA had positive earnings in the past year.
In the past year AXA had a positive cash flow from operations.
Each year in the past 5 years AXA has been profitable.
AXA had a positive operating cash flow in each of the past 5 years.
AXA.DE Yearly Net Income VS EBIT VS OCF VS FCFAXA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

AXA's Return On Assets of 1.18% is in line compared to the rest of the industry. AXA outperforms 56.41% of its industry peers.
AXA's Return On Equity of 15.39% is fine compared to the rest of the industry. AXA outperforms 64.10% of its industry peers.
AXA's Return On Invested Capital of 1.33% is in line compared to the rest of the industry. AXA outperforms 56.41% of its industry peers.
AXA had an Average Return On Invested Capital over the past 3 years of 1.29%. This is in line with the industry average of 2.14%.
The last Return On Invested Capital (1.33%) for AXA is above the 3 year average (1.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROIC 1.33%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
AXA.DE Yearly ROA, ROE, ROICAXA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 8.80%, AXA is in line with its industry, outperforming 48.72% of the companies in the same industry.
AXA's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 12.32%, AXA is in line with its industry, outperforming 53.85% of the companies in the same industry.
In the last couple of years the Operating Margin of AXA has grown nicely.
Industry RankSector Rank
OM 12.32%
PM (TTM) 8.8%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
AXA.DE Yearly Profit, Operating, Gross MarginsAXA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

AXA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AXA has less shares outstanding
Compared to 5 years ago, AXA has less shares outstanding
AXA has a worse debt/assets ratio than last year.
AXA.DE Yearly Shares OutstandingAXA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
AXA.DE Yearly Total Debt VS Total AssetsAXA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

AXA has an Altman-Z score of 0.35. This is a bad value and indicates that AXA is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 0.35, AXA belongs to the best of the industry, outperforming 89.74% of the companies in the same industry.
AXA has a debt to FCF ratio of 2.19. This is a good value and a sign of high solvency as AXA would need 2.19 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.19, AXA is in the better half of the industry, outperforming 74.36% of the companies in the same industry.
A Debt/Equity ratio of 0.53 indicates that AXA is somewhat dependend on debt financing.
AXA's Debt to Equity ratio of 0.53 is fine compared to the rest of the industry. AXA outperforms 64.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Altman-Z 0.35
ROIC/WACC0.13
WACC10.45%
AXA.DE Yearly LT Debt VS Equity VS FCFAXA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

A Current Ratio of 0.87 indicates that AXA may have some problems paying its short term obligations.
AXA has a Current ratio of 0.87. This is amongst the best in the industry. AXA outperforms 87.18% of its industry peers.
A Quick Ratio of 0.87 indicates that AXA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.87, AXA belongs to the top of the industry, outperforming 87.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
AXA.DE Yearly Current Assets VS Current LiabilitesAXA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

AXA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.08%, which is quite good.
AXA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.09% yearly.
Looking at the last year, AXA shows a small growth in Revenue. The Revenue has grown by 4.38% in the last year.
Measured over the past years, AXA shows a decrease in Revenue. The Revenue has been decreasing by -8.16% on average per year.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%

3.2 Future

Based on estimates for the next years, AXA will show a small growth in Earnings Per Share. The EPS will grow by 5.12% on average per year.
The Revenue is expected to grow by 7.15% on average over the next years.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.15%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AXA.DE Yearly Revenue VS EstimatesAXA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
AXA.DE Yearly EPS VS EstimatesAXA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.55, which indicates a very decent valuation of AXA.
Based on the Price/Earnings ratio, AXA is valued a bit cheaper than 69.23% of the companies in the same industry.
AXA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.18.
Based on the Price/Forward Earnings ratio of 10.35, the valuation of AXA can be described as reasonable.
AXA's Price/Forward Earnings is on the same level as the industry average.
AXA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.34.
Industry RankSector Rank
PE 11.55
Fwd PE 10.35
AXA.DE Price Earnings VS Forward Price EarningsAXA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

AXA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AXA is cheaper than 64.10% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.66
EV/EBITDA N/A
AXA.DE Per share dataAXA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AXA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1
PEG (5Y)0.64
EPS Next 2Y9.13%
EPS Next 3Y8.44%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.16%, AXA is a good candidate for dividend investing.
AXA's Dividend Yield is a higher than the industry average which is at 4.54.
AXA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 5.16%

5.2 History

The dividend of AXA is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
AXA.DE Yearly Dividends per shareAXA.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

AXA pays out 57.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
AXA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
AXA.DE Yearly Income VS Free CF VS DividendAXA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
AXA.DE Dividend Payout.AXA.DE Dividend Payout, showing the Payout Ratio.AXA.DE Dividend Payout.PayoutRetained Earnings

AXA SA

FRA:AXA (7/15/2025, 7:00:00 PM)

41.46

-0.32 (-0.77%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-19 2025-03-19/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners33.99%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap91.86B
Analysts81.54
Price Target43.85 (5.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.16%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.61%
Valuation
Industry RankSector Rank
PE 11.55
Fwd PE 10.35
P/S 1.05
P/FCF 7.66
P/OCF 7.37
P/B 1.84
P/tB 3.35
EV/EBITDA N/A
EPS(TTM)3.59
EY8.66%
EPS(NY)4.01
Fwd EY9.66%
FCF(TTM)5.41
FCFY13.05%
OCF(TTM)5.63
OCFY13.57%
SpS39.42
BVpS22.54
TBVpS12.36
PEG (NY)1
PEG (5Y)0.64
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROCE 1.67%
ROIC 1.33%
ROICexc 1.37%
ROICexgc 1.79%
OM 12.32%
PM (TTM) 8.8%
GM N/A
FCFM 13.73%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.54%
Interest Coverage 1.72
Cash Conversion N/A
Profit Quality 156.03%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.35
F-Score7
WACC10.45%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.15%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%